Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Prediction of Hepatic Complications after Allogeneic Haemotopoetic Stem Cell Transplantation Using Liver and Spleen Stiffness Measurement

Georg-Nikolaus Franke, MD, Tina Weiße, MD, David Petroff, PhD, Sebastian Beer, MD, Christine Döhring, MD, Gerhard Behre, MD, Janett Fischer, Franziska Lindner, Johannes Wiegand, Volker Keim, MD, Dietger Niederwieser, MD, Thomas Karlas, MD

Blood (2018) 132 (Supplement 1): 2073.

https://doi.org/10.1182/blood-2018-99-111463

Published: 2018

Journal Articles

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

Vladan Vucinic, Saskia Hell, Madlen Jentzsch, MD, Michael Cross, PhD, Sabine Leiblein, Wolfram Pönisch, MD, Georg-Nikolaus Franke, MD, Gerhard Behre, MD, Thoralf Lange, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD

Blood (2017) 130 (Supplement 1): 3230.

https://doi.org/10.1182/blood.V130.Suppl_1.3230.3230

Published: 2017

Journal Articles

Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Kathrin Wildenberger, Christine Günther, Michael Cross, PhD, Thomas Ernst, MD, Christian Fabisch, PhD, Dietger Niederwieser, MD, Andreas Hochhaus, MD, Thoralf Lange, MD

Blood (2017) 130 (Supplement 1): 252.

https://doi.org/10.1182/blood.V130.Suppl_1.252.252

Published: 2017

Journal Articles

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

Stefanie Beinicke, MSc, Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, PhD, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 2037.

https://doi.org/10.1182/blood.V130.Suppl_1.2037.2037

Published: 2017

Journal Articles

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

Janine Häntschel, MSc, Madlen Jentzsch, MD, Juliane Grimm, Marius Bill, Stefanie Beinicke, MSc, Laura K. Schmalbrock, MD, Lynn Bonifacio, MD, Luba Schuhmann, Julia Schulz, Karoline Goldmann, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 1203.

https://doi.org/10.1182/blood.V130.Suppl_1.1203.1203

Published: 2017

Journal Articles

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

Juliane Grimm, Marius Bill, PhD, Madlen Jentzsch, MD, Stefanie Beinicke, MSc, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Wolfram Pönisch, MD, Vladan Vucinic, Gerhard Behre, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 406.

https://doi.org/10.1182/blood.V130.Suppl_1.406.406

Published: 2017

Journal Articles

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

Marius Bill, MD PhD, Madlen Jentzsch, MD, Julia Schulz, Karoline Schubert, Juliane Grimm, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Gerhard Behre, MD, Vladan Vucinic, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 1698.

https://doi.org/10.1182/blood.V128.22.1698.1698

Published: 2016

Journal Articles

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

Madlen Jentzsch, MD, Marius Bill, MDPhD, Julia Schulz, Juliane Grimm, Stefanie Beinicke, Karoline Schubert, Janine Haentschel, Kathrin Wildenberger, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 517.

https://doi.org/10.1182/blood.V128.22.517.517

Published: 2016

Journal Articles

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, MD PhD, Julia Schulz, Karoline Schubert, Stefanie Beinicke, Janine Haentschel, Luba Schuhmann, Michael Cross, PhD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5092.

https://doi.org/10.1182/blood.V128.22.5092.5092

Published: 2016

Journal Articles

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Florian Ramdohr, MD, Marius Bill, MD PhD, Madlen Jentzsch, MD, Karoline Schubert, Juliane Grimm, Julia Schulz, Luba Schuhmann, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5110.

https://doi.org/10.1182/blood.V128.22.5110.5110

Published: 2016

Journal Articles

Increasing the Sensitivity of BCR-ABL Monitoring By Digital PCR By Reducing the Background Noise

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Svilen Tzonev, PhD, Dawne Naomi Shelton, PhD, Michael Cross, PhD, Kathrin Wildenberger, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2016) 128 (22): 3085.

https://doi.org/10.1182/blood.V128.22.3085.3085

Published: 2016

Journal Articles

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, MD, Luba Schuhmann, Marius Bill, MDPhD, Sabine Leiblein, PhD, Ulrike Bergmann, Martina Pless, Karoline Schubert, Laura Katharina Schmalbrock, MD, Juliane Grimm, Maria Knyrim, Wolfram Poenisch, MD, Georg-Nikolaus Franke, MD, Vladan Vucinic, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2573.

https://doi.org/10.1182/blood.V126.23.2573.2573

Published: 2015

Journal Articles

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Kathrin Wildenberger, Michael Cross, PhD, Oliver Frank, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Christian T. Dietz, PhD, Martin C. Müller, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2015) 126 (23): 135.

https://doi.org/10.1182/blood.V126.23.135.135

Published: 2015

Journal Articles

Prognostic Impact of Aberrant RUNX1 Expression in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Maria Knyrim, Madlen Jentzsch, MD, Marius Bill, MDPhD, Juliane Grimm, Karoline Schubert, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Vladan Vucinic, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 3829.

https://doi.org/10.1182/blood.V126.23.3829.3829

Published: 2015

Journal Articles

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Madlen Jentzsch, MD, Elena Ruschpler, Sabine Leiblein, PhD, Yvonne Remane, Jan-Phillip Stümpel, MD, Georg-Nikolaus Franke, MD, Simone Heyn, MD, Nadja Jaekel, MD, Susann Schulze, MD, Song-Yau Wang, MD, Wolfram Poenisch, MD, Claudia Nehring, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD, Vladan Vucinic, MD

Blood (2015) 126 (23): 5439.

https://doi.org/10.1182/blood.V126.23.5439.5439

Published: 2015

Journal Articles

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Marius Bill, MDPhD, Madlen Jentzsch, MD, Luba Schuhmann, Juliane Grimm, Maria Knyrim, Laura Katharina Schmalbrock, MD, Schubert Karoline, Michael Cross, PhD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Thoralf Lange, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2032.

https://doi.org/10.1182/blood.V126.23.2032.2032

Published: 2015

Journal Articles

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Juliane Grimm, Marius Bill, MDPhD, Laura Kloss, Madlen Jentzsch, MD, Maria Knyrim, Karoline Schubert, Christine Guenther, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 4398.

https://doi.org/10.1182/blood.V126.23.4398.4398

Published: 2015

Journal Articles

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Sebastian Schwind, MD, Madlen Jentzsch, MD, Marius Bill, PhD, Karoline Schubert, Laura Schmalbrock, Heike Weidner, Laura Kloss, Taqiuddine Gaber, Lynn Bonifacio, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 732.

https://doi.org/10.1182/blood.V124.21.732.732

Published: 2014

Journal Articles

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Karoline Schubert, Michael Cross, PhD, Sabine Leiblein, Kathrin Wildenberger, Frank Giles, MDMB, Andreas Hochhaus, MD, Oliver Frank, PhD, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2014) 124 (21): 3143.

https://doi.org/10.1182/blood.V124.21.3143.3143

Published: 2014

Journal Articles

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

Taqiuddine Gaber, Marius Bill, PhD, Madlen Jentzsch, MD, Karoline Schubert, Heike Weidner, Laura Kloss, Laura Schmalbrock, Bonifacio Lynn, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2014) 124 (21): 1037.

https://doi.org/10.1182/blood.V124.21.1037.1037

Published: 2014

NARROW

Prediction of Hepatic Complications after Allogeneic Haemotopoetic Stem Cell Transplantation Using Liver and Spleen Stiffness Measurement

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Increasing the Sensitivity of BCR-ABL Monitoring By Digital PCR By Reducing the Background Noise

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

Prognostic Impact of Aberrant RUNX1 Expression in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only